Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056771427> ?p ?o ?g. }
- W2056771427 endingPage "150" @default.
- W2056771427 startingPage "141" @default.
- W2056771427 abstract "Long-acting nanoformulated antiretroviral therapy (nanoART) that targets monocyte-macrophages could improve the drug's half-life and protein-binding capacities while facilitating cell and tissue depots. To this end, ART nanoparticles that target the folic acid (FA) receptor and permit cell-based drug depots were examined using pharmacokinetic and pharmacodynamic (PD) tests. FA receptor-targeted poloxamer 407 nanocrystals, containing ritonavir-boosted atazanavir (ATV/r), significantly increased drug bioavailability and PD by five and 100 times, respectively. Drug particles administered to human peripheral blood lymphocyte reconstituted NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice and infected with HIV-1ADA led to ATV/r drug concentrations that paralleled FA receptor beta staining in both the macrophage-rich parafollicular areas of spleen and lymph nodes. Drug levels were higher in these tissues than what could be achieved by either native drug or untargeted nanoART particles. The data also mirrored potent reductions in viral loads, tissue viral RNA and numbers of HIV-1p24+ cells in infected and treated animals. We conclude that FA-P407 coating of ART nanoparticles readily facilitates drug carriage and antiretroviral responses." @default.
- W2056771427 created "2016-06-24" @default.
- W2056771427 creator A5000994320 @default.
- W2056771427 creator A5018546819 @default.
- W2056771427 creator A5020379762 @default.
- W2056771427 creator A5023736838 @default.
- W2056771427 creator A5026111070 @default.
- W2056771427 creator A5032770226 @default.
- W2056771427 creator A5039031957 @default.
- W2056771427 creator A5042126168 @default.
- W2056771427 creator A5047378642 @default.
- W2056771427 creator A5048851127 @default.
- W2056771427 creator A5051311967 @default.
- W2056771427 creator A5051999877 @default.
- W2056771427 creator A5054703440 @default.
- W2056771427 creator A5061751755 @default.
- W2056771427 creator A5063736389 @default.
- W2056771427 creator A5078751891 @default.
- W2056771427 creator A5089862290 @default.
- W2056771427 date "2015-02-01" @default.
- W2056771427 modified "2023-09-23" @default.
- W2056771427 title "Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulations" @default.
- W2056771427 cites W108344161 @default.
- W2056771427 cites W1567210531 @default.
- W2056771427 cites W1577145524 @default.
- W2056771427 cites W1904077044 @default.
- W2056771427 cites W1971071816 @default.
- W2056771427 cites W1972921119 @default.
- W2056771427 cites W1980697071 @default.
- W2056771427 cites W1982222817 @default.
- W2056771427 cites W1982612158 @default.
- W2056771427 cites W1985830416 @default.
- W2056771427 cites W1989277325 @default.
- W2056771427 cites W1997581567 @default.
- W2056771427 cites W2003113416 @default.
- W2056771427 cites W2004335567 @default.
- W2056771427 cites W2016613470 @default.
- W2056771427 cites W2020041520 @default.
- W2056771427 cites W2034414496 @default.
- W2056771427 cites W2036271995 @default.
- W2056771427 cites W2042258507 @default.
- W2056771427 cites W2043724352 @default.
- W2056771427 cites W2044352000 @default.
- W2056771427 cites W2046842773 @default.
- W2056771427 cites W2049259580 @default.
- W2056771427 cites W2051122335 @default.
- W2056771427 cites W2056211275 @default.
- W2056771427 cites W2069618188 @default.
- W2056771427 cites W2075144974 @default.
- W2056771427 cites W2078912182 @default.
- W2056771427 cites W2083017413 @default.
- W2056771427 cites W2085167526 @default.
- W2056771427 cites W2090884085 @default.
- W2056771427 cites W2093076993 @default.
- W2056771427 cites W2101302825 @default.
- W2056771427 cites W2104407049 @default.
- W2056771427 cites W2106408660 @default.
- W2056771427 cites W2111022078 @default.
- W2056771427 cites W2116204495 @default.
- W2056771427 cites W2124268946 @default.
- W2056771427 cites W2142651063 @default.
- W2056771427 cites W2144190487 @default.
- W2056771427 cites W2155109292 @default.
- W2056771427 cites W2164944270 @default.
- W2056771427 cites W2167974020 @default.
- W2056771427 cites W2169422073 @default.
- W2056771427 cites W2171273743 @default.
- W2056771427 cites W4299899527 @default.
- W2056771427 doi "https://doi.org/10.1016/j.biomaterials.2014.11.012" @default.
- W2056771427 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4272445" @default.
- W2056771427 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25522973" @default.
- W2056771427 hasPublicationYear "2015" @default.
- W2056771427 type Work @default.
- W2056771427 sameAs 2056771427 @default.
- W2056771427 citedByCount "60" @default.
- W2056771427 countsByYear W20567714272015 @default.
- W2056771427 countsByYear W20567714272016 @default.
- W2056771427 countsByYear W20567714272017 @default.
- W2056771427 countsByYear W20567714272018 @default.
- W2056771427 countsByYear W20567714272019 @default.
- W2056771427 countsByYear W20567714272020 @default.
- W2056771427 countsByYear W20567714272021 @default.
- W2056771427 countsByYear W20567714272022 @default.
- W2056771427 countsByYear W20567714272023 @default.
- W2056771427 crossrefType "journal-article" @default.
- W2056771427 hasAuthorship W2056771427A5000994320 @default.
- W2056771427 hasAuthorship W2056771427A5018546819 @default.
- W2056771427 hasAuthorship W2056771427A5020379762 @default.
- W2056771427 hasAuthorship W2056771427A5023736838 @default.
- W2056771427 hasAuthorship W2056771427A5026111070 @default.
- W2056771427 hasAuthorship W2056771427A5032770226 @default.
- W2056771427 hasAuthorship W2056771427A5039031957 @default.
- W2056771427 hasAuthorship W2056771427A5042126168 @default.
- W2056771427 hasAuthorship W2056771427A5047378642 @default.
- W2056771427 hasAuthorship W2056771427A5048851127 @default.
- W2056771427 hasAuthorship W2056771427A5051311967 @default.
- W2056771427 hasAuthorship W2056771427A5051999877 @default.
- W2056771427 hasAuthorship W2056771427A5054703440 @default.